ClinicalTrials.gg
Sign In

BiologicalDrug

Anti-CD7 CAR T-cells clinical trials

studies test it
10
open now
6
in phase 3
0
first study started
2019

Keep track of what changes. Save the Anti-CD7 CAR T-cells studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Name

CD7 CAR-T cells injection
5
CD7 CAR-T cells infusion
2

Studies by the year they started

10 studies that test it; most in 2022 (3)

Studies that test Anti-CD7 CAR T-cells, by start year
YearStudies
20191
20201
20223
20231
20241
20253

By phase

A phase 1/2 study counts in both.

Early Phase 1
4
Phase 1
5
Phase 2
2
No phase
1

What it is tested for

Each study’s main condition, where its own words name it.

Lymphoma, T-Cell
3
Hematologic Diseases
1
Bone Marrow Failure Disorders
1
Anemia, Aplastic
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Dermatomyositis
1
Lymphoma
1

Who runs them

Industry 3 · Other 7

Zhejiang University (5) · iCell Gene Therapeutics (2) · Beijing GoBroad Hospital (1) · Shenzhen University General Hospital (1) · PersonGen BioTherapeutics (Suzhou) Co., Ltd. (1)

Studies

Open first, then newest update. How each study uses Anti-CD7 CAR T-cells is read from its arms, and is right about nine times in ten.

Testing it · 10